drugset / Trial / NCT04545801

Ketamine for Analgesia After Cesarean Section

NCT04545801 ↗

Completed 80 enrolled Mongi Slim Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

In this prospective randomized trial, investigators compared the analgesic effect of subanesthetic dose of ketamine versus placebo in parturients undergoing cesarean section under spinal anesthesia.

Timeline

Start
2019-01-01
Primary completion
2019-03-31
Completion
2019-04-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 0.25 mg/kg Intravenous

Indications

No indication recorded.